Healthcare ❯ Pharmaceuticals

Abortion Medications

Mifepristone Mifepristone and Misoprostol Patient Safety Patient Privacy

Supreme Court Pauses 5th Circuit Order, Temporarily Restores Mail and Telehealth Access to Abortion Pill

A one-week administrative stay preserves the FDA’s 2023 telehealth policy pending review of emergency appeals.

Supreme Court Temporarily Restores Mail and Telehealth Access to Abortion Pill

Supreme Court Temporarily Restores Mail and Telehealth Access to Mifepristone

Appeals Court Blocks Mailed Abortion Pills, Reinstates In-Person Pickup Nationwide

Report Says Complications Rose After FDA Allowed Mail-Order Abortion Pills

Paxton Sues Delaware Nurse Practitioner Over Abortion Pills Mailed to Texans

Republicans Press Trump Administration to Halt Mail-Order Abortion Pills Crossing State Lines

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

Texas Enacts $100,000 Private Lawsuits Over Mailed Abortion Pills

Missouri AG Files Suit Over Planned Parenthood’s Mifepristone Safety Claims

New York Enacts Law to Protect Abortion Pill Prescribers from Out-of-State Prosecution

Texas Judge Allows Republican-Led States to Challenge Abortion Pill Regulations

Texas Lawsuit Against New York Doctor Tests Legal Boundaries of Abortion Pill Access

Legal Battles Intensify Over Abortion Pills in the U.S.

Scientists Sue Journal Over Retraction of Abortion Pill Studies

Louisiana Reclassifies Abortion Pills as Controlled Substances, Raising Health Concerns